Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for LOXAPINE
- AGItated Patients Management: intraNASAL Midazolam vs Intramuscular Loxapine
- A Study of Staccato Loxapine (ADASUVE®) for Inhalation
- Saxenda® in Obese or Overweight Patients With Stable Bipolar Disorder (Investigator Initiated)
- Inhaled Loxapine vs Intramuscular (IM) Haloperidol + Lorazepam for Agitation
- Tolerability and Analgesic Efficacy of Loxapine in Patients With Refractory, Chemotherapy-induced Neuropathic Pain
- Family Intervention in Recent Onset Schizophrenia Treatment (FIRST)
- Antipsychotics and Risk of Hyperglycemic Emergencies
- Study to Assess the Safety and Pharmacokinetics of ADASUVE® at Doses of 2.5, 5, or 10 mg in Children and Adolescents (10 Through 17 Years of Age) With Any Condition Warranting Chronic Use of an Antipsychotic Medication
- Loxapine in the Management of Restlessness During Mechanical Ventilation Weaning
- Staccato Loxapine Pulmonary Safety in Patients With Asthma
- Staccato Loxapine Pulmonary Safety in Patients With COPD
- Staccato Loxapine Thorough QT/QTc Study
- Staccato Loxapine PK in Smokers and Nonsmokers
- Haloperidol vs Olanzapine for the Management of ICU Delirium
- Staccato Loxapine in Migraine (Out Patient)
- Staccato Loxapine Pulmonary Safety in Healthy Volunteers
- Staccato Loxapine in Agitated Patients With Bipolar Disorder
- Fasting Study of Loxapine Succinate Capsules 25 mg and Loxitane® Capsules 25 mg
- Staccato Loxapine in Agitated Patients With Schizophrenia
- Staccato Loxapine Multidose PK
- Staccato Loxapine in Migraine (in Clinic)
- Staccato Loxapine Single Dose PK
- Staccato Loxapine in Agitation (Proof of Concept)
- Randomized Double-blind Trial of Midazolam and Loxapine in Agitated Patients
- Loxapine and Weaning From Ventilator
Clinical trials list
click for details